Advertisement
Review ArticleReview Article
Open Access

Allosteric Modulators of Metabotropic Glutamate Receptors as Novel Therapeutics for Neuropsychiatric Disease

Deborah J. Luessen and P. Jeffrey Conn
Lynette Daws, ASSOCIATE EDITOR
Pharmacological Reviews July 2022, 74 (3) 630-661; DOI: https://doi.org/10.1124/pharmrev.121.000540

Article Information

vol. 74 no. 3 630-661
DOI 
https://doi.org/10.1124/pharmrev.121.000540
PubMed 
35710132
Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0031-6997
Online ISSN 
1521-0081
History 
  • Published online June 16, 2022.
Copyright & Usage 
Copyright © 2022 by The Author(s) This is an open access article distributed under the CC BY-NC Attribution 4.0 International license.

Author Information

  1. Deborah J. Luessen and
  2. P. Jeffrey Conn
  1. Lynette Daws, ASSOCIATE EDITOR
  1. Vanderbilt University Medical Center, Nashville, Tennesee
  1. Address correspondence to:
    Dr. Deborah J. Luessen, Vanderbilt University Medical Center, 1205 Light Hall, Nashville, TN 37232. E-mail: deborah.j.luessen{at}vanderbilt.edu
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: June 2022 to January 2023

AbstractFullPdf
Jun 20221632245
Jul 20225443180
Aug 202213414156
Sep 20221131688
Oct 20221920062
Nov 20221715260
Dec 202299663
Jan 2023167752

Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

Review ArticleReview Article

mGlu Receptor Allosteric Modulators as Novel Therapeutics

Deborah J. Luessen and P. Jeffrey Conn
Pharmacological Reviews July 1, 2022, 74 (3) 630-661; DOI: https://doi.org/10.1124/pharmrev.121.000540
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo

Jump to section

Advertisement